Bristol Myers Squibb
OPDIVO
Manufacturer:
Bristol Myers Squibb
Name:
OPDIVO
HCPCS Code Descriptor:
Injection, nivolumab, 1 mg
Category:
J Code
HCPCS:
J9299
NDC(s):
00003-3772-11, 00003-3774-12, 00003-3756-14, 00003-3734-13
Primary Type:
Oncology
Generic Status:
Single-Source
Route of Administration:
Intravenous
About:
OPDIVO is an Oncology drug manufactured by Bristol Myers Squibb and administered via the Intravenous route of administration. The J Code: J9299 is aligned to the drug OPDIVO.
Access Pricing and More By Registering
HCPCS Added Date:
1/1/16
HCPCS Effective Date:
1/1/16
HCPCS Short Description:
Injection, nivolumab
Billing and Coding Guide:
https://www.bmsaccesssupport.bmscustomerconnect.com/servlet/servlet.FileDownload?file=00Pi000000nzXaoEAE
Patient Assistance:
https://www.bmsaccesssupport.bmscustomerconnect.com/patient
https://www.bmsaccesssupport.bmscustomerconnect.com/patient